Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Updated on: December 12,2024

Discovery of molecular mechanism involved in early brain development provides insights into microcephaly pathogenesis

byTohoku UniversityAn overview of Kif23's involvement in embryonic brain development, highlighting how its deficiency disrupts cell division and potentially contribute to microcephaly. Credi

Updated on:December 12,2024

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Updated on: April 08,2024

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Updated on:April 08,2024

Impact of Transfusion Strategies on Neurological Recovery in Acute Brain Injury: Insights from a Multicenter Randomized Trial

Updated on: January 09,2025

Impact of Transfusion Strategies on Neurological Recovery in Acute Brain Injury: Insights from a Multicenter Randomized Trial

Updated on:January 09,2025

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on: May 13,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on:May 13,2024

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Updated on: February 28,2024

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Updated on:February 28,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on: December 17,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on:December 17,2024

Alzheimer's patients exhibit changes in blood lipids typical of premature ageing

by Medical University of ViennaAlzheimer's disease: patients exhibit changes in certain blood lipids that are typical of premature ageing. Credit: Medical University of ViennaThe neurodegener

Updated on: March 09,2024

Alzheimer's patients exhibit changes in blood lipids typical of premature ageing

by Medical University of ViennaAlzheimer's disease: patients exhibit changes in certain blood lipids that are typical of premature ageing. Credit: Medical University of ViennaThe neurodegener

Updated on:March 09,2024

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Updated on: March 09,2024

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Updated on:March 09,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on: April 10,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on:April 10,2024

How inflammation alters nerve cell responses to make touch painful

Updated on: May 15,2025

How inflammation alters nerve cell responses to make touch painful

Updated on:May 15,2025

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024